LB PHARMACEUTICALS INC Q2 2026: Revenue $0 Net loss $(51.6M), EPS $(1.71) — 10-Q Summary
LB PHARMACEUTICALS INC (LBRX) reported a net loss of $(51.6M) and diluted loss per share of $(1.71) for Q2 2026, with no product revenue. This compares to a net loss of $(4.9M) and diluted EPS of $(13.58) in Q2 2025. The company highlighted pipeline …